Your Brain, Your ADHD: New Research Suggests There Isn't Just One Kind

“Check out the big brain on Brad!”

Executive Summary (For Those With Executive Dysfunction)

A large new brain-imaging study out of JAMA Psychiatry (Feb 2026) scanned the brains of over 1,700 kids with and without ADHD and found something a lot of us have suspected for a long time: ADHD isn't one single thing. Using MRI scans and some seriously heavy-duty statistics, researchers identified three distinct "biotypes" of ADHD, each with its own brain signature, its own symptom pattern, and its own likely underlying brain chemistry. One biotype looks like a combined, emotionally intense presentation. One looks mostly hyperactive/impulsive. One looks mostly inattentive. The findings held up when tested on a second, completely separate group of kids, which is the kind of replication that makes scientists sit up. This doesn't change how ADHD is diagnosed today, and it's not a brain scan you can go get to "find out your biotype." But it's a real step toward the field admitting that a diagnosis built on a checklist from the 1990s might not capture what's actually happening in different people's brains — and that's worth talking about.

The Story So Far

If you've ever sat in a room with three other people who all "have ADHD" and thought, we do not have the same disorder, you're not wrong, and now there's brain data to back you up.

For decades, ADHD has been diagnosed the same way: a clinician checks off which of nineteen behaviors from the DSM-5 you display, sorts you into inattentive, hyperactive/impulsive, or combined type, and that's that. It's a system built on symptom checklists, not biology. It works well enough to get people help, but it's always had an obvious problem — it assumes that everyone who checks the "distracted" box and everyone who checks the "fidgety" box got there through the same neurological route. Anyone who has ADHD, or loves someone who does, knows that doesn't feel true. The kid who can't sit still and the kid who stares out the window in a fog don't seem like they're experiencing the same disorder wearing different outfits.

A team of researchers across China, Australia, and the US decided to test whether the brain itself tells a more nuanced story. Instead of starting with symptoms and asking "what brain differences go with this," they flipped the approach: start with the brain, and see what patterns emerge on their own.

What They Actually Did

The tool they used is called a morphometric similarity network, which is a fancy way of describing how similar different brain regions are to each other in their physical structure — thickness, folding, volume, that kind of thing. Regions that are structurally similar tend to be more interconnected, and some regions act as "hubs," similar to how a major airport is more connected to the rest of the world than a small regional airstrip. The researchers measured how "hub-like" different brain regions were in each child's brain using three separate measurements, then compared each child's brain to a normative model — essentially a growth chart, but for brain network organization instead of height and weight. Just like a pediatrician can tell you a child's height percentile compared to same-age, same-sex peers, this method can say how much a given brain region deviates from what's typical for that child's age.

They ran this on 446 children with ADHD and 708 typically developing kids pulled from six different research sites in the US and China (discovery cohort), and then tested whether their findings held up in a completely separate group of 554 children with ADHD and 123 controls from an independent dataset (validation cohort). That second step matters enormously — a lot of splashy brain-science findings never get retested, and a shocking number fail to replicate when someone else runs the same analysis. This one held up.

Using a clustering technique that's designed to find real subgroups within a population rather than forcing everyone into predetermined buckets, three biotypes emerged from the ADHD group:

Biotype 1 — Severe-Combined with Emotional Dysregulation (142 kids). Widespread differences concentrated in the connections between the medial prefrontal cortex and the pallidum, a deep brain structure involved in movement and reward processing. This group scored highest on both inattention and hyperactivity/impulsivity measures, had the most extensive brain deviations of the three groups by a wide margin, and showed more persistent difficulty with emotional self-regulation over time compared to the other two biotypes. They also showed a higher (though not statistically significant) rate of co-occurring mood disorders like anxiety and depression.

Biotype 2 — Predominantly Hyperactive/Impulsive (177 kids). Differences centered on the anterior cingulate cortex and its connection to the pallidum — circuitry tied to action selection and impulse control.

Biotype 3 — Predominantly Inattentive (127 kids). Differences concentrated in the superior frontal gyrus, an area involved in sustained attention and self-directed thought.

Here's the part that should give you a little bit of chills if you've ever felt unseen by the standard ADHD categories: these three groups were identified purely from brain scans, with zero input from symptom checklists. And when the researchers went back and looked at each biotype's actual clinical profile afterward, the brain-based groupings lined up remarkably well with the inattentive, hyperactive/impulsive, and combined presentations that clinicians already use. In other words, the brain wasn't inventing new categories out of nowhere — it was independently confirming that the old clinical intuition about different "flavors" of ADHD was picking up on something real.

The Chemistry Underneath

The researchers didn't stop at brain structure. They also mapped each biotype's pattern of brain differences against known maps of where different neurotransmitter receptors sit in the brain — receptors for serotonin, dopamine, acetylcholine, histamine, glutamate, and cannabinoid signaling, among others.

Biotype 1 (the severe-combined, emotionally dysregulated group) showed the strongest correlations with serotonin and acetylcholine receptor distributions, alongside dopamine and histamine involvement. Biotype 2 (hyperactive/impulsive) showed the opposite pattern with several of these systems — its brain differences ran counter to where cannabinoid, glutamate, and certain serotonin receptors are concentrated. Biotype 3 (inattentive) showed a narrower, more selective relationship, mainly with one serotonin receptor subtype.

It's worth being honest about what this chemistry mapping can and can't tell us. The researchers themselves note this is exploratory — it shows where brain structure differences overlap with where certain receptors happen to sit, not that those specific receptors are malfunctioning, and definitely not a roadmap for which medication should work best for which biotype. Think of it less like a treatment manual and more like a very early, blurry photograph of a much bigger picture that future research will need to sharpen.

Why This Actually Matters

The most exciting sentence buried in this paper isn't really about biology — it's about validation. For a long time, the "different kinds of ADHD" conversation has lived mostly in the realm of personal experience and clinical intuition: the kid who's bouncing off the walls versus the kid who's quietly drowning in a fog versus the kid who's both, plus big emotions on top. This study is one of the more rigorous attempts to show that those differences might correspond to measurably different brain organization, not just different degrees of the same thing.

It also reframes what a "biotype" even is. Biotype 1 wasn't just "worse ADHD" — it was different ADHD, with the most widespread brain differences, the most persistent emotional regulation struggles over time, and a distinct chemical signature. That has real implications for how we think about severity, comorbidity, and what kind of support someone might need, especially kids who are managing big emotions on top of attention and impulsivity challenges.

What This Doesn't Mean (Yet)

This is not a diagnostic test. Nobody is getting an MRI to find out their ADHD biotype next year, or probably for a long while. The overlap between ADHD brains and typically developing brains in this study was still substantial — these are population-level patterns, not clean dividing lines you could draw around an individual scan. The sample also wasn't medication-naive, meaning some participants were already taking ADHD medication, which could subtly influence the brain measurements even though the researchers note this hasn't shown a major effect in past large-scale studies. And most participants didn't report race or ethnicity data, so we don't yet know how well these three biotypes generalize across different populations.

The researchers are also careful to describe these biotypes as possibly representing points along a spectrum rather than three hard, separate categories — more like three well-lit spots on a dimmer switch than three light switches you flip on or off.

The Bottom Line

This study won't change how you or your kid gets diagnosed tomorrow. But it's a meaningful piece of a much bigger shift happening in psychiatry: away from "ADHD is ADHD is ADHD" and toward a future where treatment might eventually be tailored to which biological flavor of ADHD someone actually has. For a community that has spent a long time being told to just try harder, there's something quietly validating about researchers using some of the most sophisticated brain-mapping tools available and landing, essentially, on: yeah, you're right, it's not all the same thing.

Reference: Pan N, Long Y, Qin K, et al. Mapping ADHD Heterogeneity and Biotypes by Topological Deviations in Morphometric Similarity Networks. JAMA Psychiatry. 2026;83(5):478-490.